there was a large drop in the IBB and XBI, but not as large as our Immunotankagain. Makes me wonder if there was some legal ruling, or FDA decision, or asset allocation change... Many stocks in the sector have made large runs, but not tankogen. Looks like a good trade to 16.6+. IMGN will either close at $16 or $17 on Friday, you can mark that down.